Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses

American Journal of Veterinary Research

Volumn 72, Issue 9, 2011, Pages 1234-1242

  Soma, Lawrence R ^a   Uboh, Cornelius E ^a,b   You, Yowen ^a   Guan, Fuyu ^a   Boston, Raymond C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE; HYDROCORTISONE; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HORSE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; QUANTITATIVE ANALYSIS; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; CORTISONE; FEMALE; GLUCOCORTICOIDS; HALF-LIFE; HORSES; HYDROCORTISONE; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; TRIAMCINOLONE ACETONIDE;

ANIMALIA; EQUIDAE;

EID: 80052478764     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.9.1234     Document Type: Article

References (56)

1. Ferguson DC, Dirikolu L, Hoenig M. Glucocorticoids, mineralocorticoids, and adrenolytic drugs. In: Riviere JE, Papich MG, Adams HR, eds. Veterinary pharmacology and therapeutics. 9th ed. Ames, Iowa: Wiley-Blackwell, 2009;783-784.
2. Derendorf H, Mollmann H, Gruner A, et al. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra- articular administration. Clin Pharmacol Ther 1986;39:313-317.
3. Mollmann H, Rohdewald P, Schmidt EW, et al. Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur J Clin Pharmacol 1985;29:85-89.
4. Ferguson DC, Hoenig M. Corticosteroids, mineral corticoids, and steroid synthesis inhibitors. In: Adams HR, ed. Veterinary pharmacology and therapeutics. 8th ed. Ames, Iowa: Iowa State University Press, 2001;658-658.
5. Kendall PH. Triamcinolone hexacetonide. A new corticosteroid for intra-articular therapy. Ann Phys Med 1967;9:55-58.
6. Trotter GW. Intra-articular corticosteriods. In: Mcllwraith CW, Trotter GW, eds. Joint disease in the horse. Philadelphia: WB Saunders Co, 1996;237-256.
7. Centeno LM, Moore ME. Preferred intraarticular corticosteroids and associated practice: a survey of members of the American College of Rheumatology. Arthritis Care Res 1994;7:151-155.
8. Frisbie DD, Kawcak CE, Trotter GW, et al. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J 1997;29:349-359.
9. Owen RA, Marsh JA, Hallett FR, et al. Intra-articular corticosteroid- and exercise-induced arthropathy in a horse. J Am Vet Med Assoc 1984;184:302-308.
10. Abma EM, Blanken R, De Heide LJ, et al. Cushing's syndrome caused by topical steroid therapy for psoriasis. Neth J Med 2002;60:148-150.
11. Jansen TL, Van Roon EN, Jansen TLTA. Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection. Neth J Med 2002;60:151-153.
12. Mace S, Vadas P, Pruzanski W. Anaphylactic shock induced by intraarticular injection of methylprednisolone acetate. J Rheumatol 1997;24:1191-1194.
13. Schweitzer DH, Le-Brun PP, Krishnaswami S, et al. Clinical and pharmacological aspects of accidental triamcinolone acetonide overdosage: a case study. Neth J Med 2000;56:12-16.
14. Wicki J, Droz M, Cirafici L, et al. Acute adrenal crisis in a patient treated with intraarticular steroid therapy. J Rheumatol 2000;27:510-511.
15. Armstrong RD, English J, Gibson T, et al. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571-574.
16. Autefage A, Alvinerie M, Toutain PL. Synovial fluid and plasma kinetics of methylprednisolone and methylprednisolone acetate in horses following intra-articular administration of methylprednisolone acetate. Equine Vet J 1986;18:193-198.
17. Soma LR, Uboh CE, Luo Y, et al. Pharmacokinetics of methylprednisolone acetate after intra-articular administration and its effect on endogenous hydrocortisone and cortisone secretion in horses. Am J Vet Res 2006;67:654-662.
18. Toutain PL, Alvinerie M, Fayolle P, et al. Bovine plasma and synovial fluid kinetics of methylprednisolone and methylprednisolone acetate after intra-articular administration of methylprednisolone acetate. J Pharmacol Exp Ther 1986;236:794-802.
19. Gylstorff B, Hegner D. Influence of a single i/m injection of triamcinolone hydrochloride on endogenous cortisol concentration in the horse. Possibility of assaying the effect. Prakt Tierarzt 1983;64:206-214.
20. Slone DE, Purohit RC, Ganjam VK, et al. Sodium retention and cortisol (hydrocortisone) suppression caused by dexamethasone and triamcinolone in equids. Am J Vet Res 1983;44:280-283.
21. Abraham G, Allersmeier M, Gottschalk J, et al. Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses. J Vet Pharmacol Ther 2009;32:379-387.
22. Spiess BM, Nyikos S, Stummer E, et al. Systemic dexamethasone concentration in horses after continued topical treatment with an ophthalmic preparation of dexamethasone. Am J Vet Res 1999;60:571-576.
23. Zenoble RD, Kemppainen RJ. Adrenocortical suppression by topically applied corticosteroids in healthy dogs. J Am Vet Med Assoc 1987;191:685-688.
24. French K, Pollitt CC, Pass MA. Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J Vet Pharmacol Ther 2000;23:287-292.
25. Koupai-Abyazani MR, Yu N, Esaw B, et al. Determination of triamcinolone acetonide in equine serum and urine by liquid chromatography-atmospheric pressure ionization mass spectrometry. J Anal Toxicol 1995;19:182-186.
26. Irvine CH, Alexander SL. Factors affecting the circadian rhythm in plasma cortisol concentrations in the horse. Domest Anim Endocrinol 1994;11:227-238.
27. Luo Y, Uboh CE, Soma LR, et al. Resolution, quantification and confirmation of betamethasone and dexamethasone in equine plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2005;19:825-832.
28. Luo Y, Uboh CE, Soma LR, et al. Simultaneous analysis of twenty- one glucocorticoids in equine plasma by liquid chromatography/ tandem mass spectrometry. Rapid Commun Mass Spectrom 2005;19:1245-1256.
29. International Organization for Standardization (ISO). ISO/IEC international standard 17025: general requirements for the competence of testing and calibration laboratories. Geneva: International Organization for Standardization (ISO), 1999.
30. Boston RC, Greif PC, Berman M. Conversational SAAM-an interactive program for kinetic analysis of biological systems. Comput Prog Biomed 1981;13:111-119.
31. Stefanovski D, Moate PJ, Boston RC, et al. WinSAAM: a windows- based compartmental modeling system. Metabolism 2003;52:1153-1166.
32. Wastney ME, Patterson BH, Linares OA, et al. Investigating biological systems using modeling: strategies and software. New York: Academic Press Inc, 1999;129.
33. Berman M, Schoenfeld R. Invariants in experimental data on linear kinetics and the formulation of models. J Appl Phys 1965;27:1361-1370.
34. Krzyzanski W, Jusko WJ. Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition. J Pharmacokinet Phar 2001;28:57-78.
35. Puchalski TA, Krzyzanski W, Blum RA, et al. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model. J Clin Pharmacol 2001;41:251-258.
36. Lassourd V, Gayrard V, Laroute V, et al. Cortisol disposition and production rate in horses during rest and exercise. Am J Physiol 1996;271:R25-R33.
37. Pitsiu M, Parker EM, Aarons L, et al. A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens. Ther Drug Monit 2003;25:36-40.
38. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis. Stockholm: Swedish Pharmaceutical Press, 2006;917-933.
39. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts & applications. Stockholm: Swedish Pharmaceutical Press, 2000;81-82.
40. Riviere JE. Comparitive pharmacokinetics: principles, techniques, and applications. Ames, Iowa: Iowa State Press, 1999;154.
41. Baggot JD. Principles of drug disposition in domestic animals: basis of veterinary clinical pharmacology. Philadelphia: WB Saunders Co, 1977;170-171.
42. Powers J. Statistical analysis of pharmacokinetic data. J Vet Pharmacol Ther 1990;13:113-120.
43. Chen CL, Sailor JA, Collier J, et al. Synovial and serum levels of triamcinolone following intra-articular administration of triamcinolone acetonide in the horse. J Vet Pharmacol Ther 1992;15:240-246.
44. Baxter JD, Rousseau GG. Glucocorticoid hormone action: an overview. Monogr Endocrinol 1979;12:1-24.
45. Keller-Wood M. Control of canine ACTH by corticosteroids: an integral feedback effect of steroids. Am J Physiol 1989;257: R427-R430.
46. Keller-Wood M, Leeman E, Shinsako J, et al. Steroid inhibition of canine ACTH: in vivo evidence for feedback at the corticotrope. Am J Physiol 1988;255:E241-E246.
47. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984;5:1-24.
48. Jusko WJ. Receptor-mediated pharmacodynamics of corticosteroids. Prog Clin Biol Res 1994;387:261-270.
49. Nelson DL, Cox MM. Lipids. In: Lehnenger principles of biochemistry. 2nd ed. New York: Worth Publishers, 2000;378-379.
50. Koopmans RP, Braat MC, Oosterhuis B, et al. Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model. J Pharmacol Exp Ther 1992;262:503-508.
51. Soma LR, Uboh CE, Luo Y, et al. Pharmacokinetics of dexamethasone with pharmacokinetic/pharmacodynamic model of the effect of dexamethasone on endogenous hydrocortisone and cortisone in the horse. J Vet Pharmacol Ther 2005;28:71-80.
52. Toothaker RD, Sundaresan GM, Hunt JP, et al. Oral hydrocortisone pharmacokinetics: a comparison of fluorescence and ultraviolet high-pressure liquid chromatographic assays for hydrocortisone in plasma. J Pharm Sci 1982;71:573-576.
53. Schulz P, Costa C, Widmer J, et al. Influence of the time of administration of dexamethasone 0.25 mg on cortisol secretion in normal humans. Psychopharmacology (Berl) 1986;89:293-295.
54. Rohatagi S, Hochhaus G, Mollmann H, et al. Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol 1995;35:1187-1193.
55. Reiss WG, Slaughter RL, Ludwig EA, et al. Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J Allergy Clin Immun 1990;85:1058-1066.
56. Derendorf H, Hochhaus G, Mollmann H, et al. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33:115-123.